Saira Ramasastry - 02 Jun 2022 Form 3 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
02 Jun 2022
Net transactions value
$0
Form type
3
Filing time
07 Jun 2022, 16:33:55 UTC
Previous filing
25 May 2022
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRM Stock Option (right to buy) 02 Jun 2022 Common Stock 7,500 $14.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.